Weekly epirubicin in patients with hormone refractory prostatic cancer--a two-year follow-up.
Burk
K
K
Farmitalia Carlo Erba GmbH/D-Freiburg.
Schultze-Seemann
W
W
Jonas
D
D
Rodeck
G
G
D000368:Aged; D000369:Aged, 80 and over; D000469:Alkaline Phosphatase / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood; D015251:Epirubicin / Q000008:administration & dosage* / Q000627:therapeutic use; D005500:Follow-Up Studies; D005860:Germany, West; D006801:Humans; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000473:pathology; D013997:Time Factors
D014408:Biomarkers, Tumor; D015251:Epirubicin; D000469:Alkaline Phosphatase